The DOI matches its Crossref record; 120 of the 123 references it cites were found in a registry or an index.
Cortical inhibitory neurons and schizophrenia
Abstract
Impairments in certain cognitive functions, such as working memory, are core features of schizophrenia. Convergent findings indicate that a deficiency in signalling through the TrkB neurotrophin receptor leads to reduced GABA (gamma-aminobutyric acid) synthesis in the parvalbumin-containing subpopulation of inhibitory GABA neurons in the dorsolateral prefrontal cortex of individuals with schizophrenia. Despite both pre- and postsynaptic compensatory responses, the resulting alteration in perisomatic inhibition of pyramidal neurons contributes to a diminished capacity for the gamma-frequency synchronized neuronal activity that is required for working memory function. These findings reveal specific targets for therapeutic interventions to improve cognitive function in individuals with schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduced expression of GAD67, the main GABA-synthesizing enzyme in the brain, appears to contribute to altered interneuron activity in psychosis [86,87] .”
From The traumagenic neurodevelopmental model of psychosis revisited (2014) · cites this paper as [86]
In the citing paper
“Certain classes of GABA interneurons are altered in individuals with psychosis, in particular reduced density in the anterior cingulate and reduced activity in the dorsolateral prefrontal cortex in the subpopulation expressing parvalbumin [84-86] .”
From The traumagenic neurodevelopmental model of psychosis revisited (2014) · cites this paper as [86]
In the citing paper
“Thus, the correct balance of inhibition and excitation seems to be critical for normative executive function, and conversely, disturbance of this balance is thought to be a fundamental component of psychiatric illness.69, 70”
From A role for synaptic plasticity in the adolescent development of executive function (2013) · cites this paper as [69]
In the citing paper
“Moreover, the expression of several GABA receptors and markers of inhibitory synapses are also altered in schizophrenia 50 .”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [50]
In the citing paper
“Schizophrenia is increasingly recognized as a neurodevelopmental disorder that involves alterations in brain circuits, including dysfunction of parvalbumin (PV)-positive, fast-spiking GABA neurons (1, 2).”
From Prolonged Period of Cortical Plasticity upon Redox Dysregulation in Fast-Spiking Interneurons (2015) · cites this paper as [1]
In the citing paper
“its onset is linked to a potential disruption of the physiological maturation of inhibitory neural networks consisting of fast-spiking parvalbumin-positive gamma-aminobutric acid (GABAergic) interneurons”
From Perineuronal nets and schizophrenia: The importance of neuronal coatings (2014) · cites this paper as Lewis et al., 2005
In the citing paper
“Dysfunction and/or deficient inhibitory output from PV interneurons may be a common mechanism of multiple psychiatric disorders, such as schizophrenia (SCZ) (Lewis et al. 2005), autism spectrum disorders (ASD) (Gao and Penzes 2015) and bipolar disorder (BD) (Ruden et al. 2021).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Lewis et al. 2005
In the citing paper
“Specifically, there is growing support for a hypothesis that cortical disinhibition occurs in schizophrenia, due to the disrupted functioning of inhibitory interneurons, which results in elevated E/I ratio (Lewis et al. 2005;Marin 2012).”
From Linking microcircuit dysfunction to cognitive impairment: Effects of disinhibition associated with schizophrenia in a cortical working memory model (2014) · cites this paper as Lewis et al. 2005
In the citing paper
“The prefrontal cortex is a key node in the distributed cortical network recruited during WM (Owen et al. 2005;Fuster 2008) and exhibits altered inhibitory microcircuitry in schizophrenia (Lewis et al. 2005;Bitanihirwe et al. 2009).”
From Linking microcircuit dysfunction to cognitive impairment: Effects of disinhibition associated with schizophrenia in a cortical working memory model (2014) · cites this paper as Lewis et al. 2005
In the citing paper
“Elevated prefrontal E/I ratio may result from alterations in multiple pathways that are implicated in schizophrenia.These include GABAergic deficits, such as reduced GAD67 production (Lewis et al. 2005); increased background input from other areas such as the thalamus or hippocampus (Lisman et al. 2008); or abnormal levels of neuromodulators (Laruelle et al. 2003).”
From Linking microcircuit dysfunction to cognitive impairment: Effects of disinhibition associated with schizophrenia in a cortical working memory model (2014) · cites this paper as Lewis et al. 2005
In the citing paper
“Both interneuron cell classes are altered in schizophrenia (Lewis et al. 2005;Morris et al. 2008;Bitanihirwe et al. 2009).”
From Linking microcircuit dysfunction to cognitive impairment: Effects of disinhibition associated with schizophrenia in a cortical working memory model (2014) · cites this paper as Lewis et al. 2005
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
An Integrative Theory of Prefrontal Cortex Function
Miller, E. K., & Cohen, J. D. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.167 · Cited by 12,803
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Interneurons of the neocortical inhibitory system
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1519 · Cited by 2,954
Cellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663
Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia
Weinberger, D. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020020004 · Cited by 2,025
Principles of Frontal Lobe Function
Stuss, D. T. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134971.001.0001 · Cited by 1,731
Topography Of Cognition: Parallel Distributed Networks In Primate Association Cortex
Goldman‐Rakic, P. S. (1988) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.11.030188.001033 · Cited by 1,658
Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636
Self-citationSynchronization of neuronal activity in hippocampus by individual GABAergic interneurons
Cobb, S. R., Buhl, E. H., Halasy, K., Paulsen, O., & Somogyi, P. (1995) · Nature · doi:10.1038/378075a0 · Cited by 1,498
Flagged first, then by citations
3 of the 123 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Konopaske, G. T., Sweet, R. A. & Lewis, D. A. GABA transporter-1 immunoreactivity in auditory association cortex in schizophrenia. Soc. Neurosci. Abstr. 34, 110.11 (2004).
- Peters, A. in Cerebral Cortex Vol. 1 (eds Jones, E. G. & Peters, A.) 361–380 (Plenum, New York, 1984).
Cited by
Sorted by citations
Items 701–800 of 1,012
Sullivan, E. M., Timi, P., Hong, L. E., & O’Donnell, P. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu118 · Cited by 70
Zimmer‐Bensch, G., Schanuel, S. M., Bürger, S., Weth, F., Steinecke, A., Bolz, J., & Lent, R. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhp309 · Cited by 70
Rossetti, A. C., Paladini, M. S., Riva, M. A., & Molteni, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107520 · Cited by 73
Repeated injection of MK801: An animal model of schizophrenia?
Eyjolfsson, E. M., Brenner, E., Kondziella, D., & Sonnewald, U. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.11.019 · Cited by 70
Sturman, D. A., & Moghaddam, B. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4210-10.2011 · Cited by 69
Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology
Ide, M., Ohnishi, T., Toyoshima, M., Balan, S., Maekawa, M., Shimamoto‐Mitsuyama, C., Iwayama, Y., Ohba, H., Watanabe, A., Ishii, T., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910695 · Cited by 69
Disrupted-in-Schizophrenia 1 (DISC1) Is Necessary for the Correct Migration of Cortical Interneurons
Steinecke, A., Gampe, C., Valkova, C., Kaether, C., & Bolz, J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5036-11.2012 · Cited by 69
Spatial characteristics of center-surround antagonism in younger and older adults
Betts, L. R., Sekuler, A. B., & Bennett, P. (2009) · Journal of Vision · doi:10.1167/9.1.25 · Cited by 69
Hartwich, K., Pollak, T., & Klausberger, T. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1397-09.2009 · Cited by 74
Increases in Two Truncated TrkB Isoforms in the Prefrontal Cortex of People With Schizophrenia
Wong, J., Rothmond, D. A., Webster, M. J., & Weickert, C. S. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr070 · Cited by 69
Matrisciano, F., Dong, E., Gavin, D. P., Nicoletti, F., & Guidotti, A. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070896 · Cited by 68
Altered Contextual Modulation of Primary Visual Cortex Responses in Schizophrenia
Seymour, K. J., Stein, T., Sanders, L. L. O., Guggenmos, M., Theophil, I., & Sterzer, P. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.168 · Cited by 71
Selective reorganization of GABAergic transmission in neonatal ventral hippocampal-lesioned rats
François, J., Ferrandon, A., Koning, E., Angst, M.-J., Sandner, G., & Nehlig, A. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709009985 · Cited by 68
Cruz, D. A., Weaver, C. L., Lovallo, E., Melchitzky, D. S., & Lewis, D. A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.36 · Cited by 68
Self-citationGomes, F. V., Guimarães, F. S., & Grace, A. A. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu018 · Cited by 68
Functional Access to Neuron Subclasses in Rodent and Primate Forebrain
Mehta, P., Kreeger, L., Wylie, D. C., Pattadkal, J. J., Lusignan, T., Davis, M. J., Turi, G. F., Li, W.-K., Whitmire, M. P., Chen, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.011 · Cited by 67
Lagler, M., Ozdemir, A. T., Lagoun, S., Malagon-Vina, H., Borhegyi, Z., Hauer, R., Jelem, A., & Klausberger, T. (2016) · Neuron · doi:10.1016/j.neuron.2016.08.010 · Cited by 67
Gandal, M. J., Nesbitt, A. M., McCurdy, R. M., & Alter, M. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041215 · Cited by 67
Pitts, M. W., Raman, A. V., Hashimoto, A. C., Todorovic, C., Nichols, R. A., & Berry, M. J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.017 · Cited by 67
The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis
Taylor, S. F., Grove, T. B., Ellingrod, V. L., & Tso, I. F. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz046 · Cited by 67
The plasticitome of cortical interneurons
McFarlan, A. R., Chou, C. Y. C., Watanabe, A., Cherepacha, N., Haddad, M. G., Owens, H., & Sjöström, P. J. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00663-9 · Cited by 74
Abnormal Gamma and Beta MEG Activity During Finger Movements in Early-Onset Psychosis
Wilson, T. W., Slason, E., Asherin, R. M., Kronberg, E., Teale, P. D., Reite, M. L., & Rojas, D. C. (2011) · Developmental Neuropsychology · doi:10.1080/87565641.2011.555573 · Cited by 70
Homeoprotein Signaling in the Developing and Adult Nervous System
Prochiantz, A., & Nardo, A. A. D. (2015) · Neuron · doi:10.1016/j.neuron.2015.01.019 · Cited by 85
Pietersen, C. Y., Mauney, S. A., Kim, S. S., Passeri, E., Lim, M. P., Rooney, R. J., Goldstein, J. M., Petryshen, T. L., Seidman, L. J., Shenton, M. E., et al. (2014) · Journal of Neurogenetics · doi:10.3109/01677063.2013.878339 · Cited by 67
Biophysical Modeling of Large-Scale Brain Dynamics and Applications for Computational Psychiatry
Murray, J. D., Demirtaş, M., & Anticevic, A. (2018) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.07.004 · Cited by 67
Perez, S. M., Boley, A. M., & Lodge, D. J. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0603-6 · Cited by 70
Electrophysiological Differences Between Neurogliaform Cells From Monkey and Rat Prefrontal Cortex
Povysheva, N. V., Zaitsev, A. V., Kröner, S., Krimer, O. A., Rotaru, D. C., González‐Burgos, G., Lewis, D. A., & Krimer, L. S. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00794.2006 · Cited by 68
Self-citationThe Neuroimmunology of Schizophrenia
Annya, M., Smyth, Stephen, M., & Lawrie, S. M. (2013) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2013.11.3.107 · Cited by 68
Gong, N., Zhang, M., Zhang, X.-B., Chen, L., Sun, G.-C., & Xu, T. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.10.017 · Cited by 66
Meechan, D. W., Maynard, T. M., Tucker, E. S., & LaMantia, A. (2010) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.08.005 · Cited by 66
Genetic and cognitive windows into circuit mechanisms of psychiatric disease
Arguello, P. A., & Gogos, J. A. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.007 · Cited by 70
Reconciling neuroimaging and neuropathological findings in schizophrenia and bipolar disorder
Fornito, A., Yücel, M., & Pantelis, C. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32832a1353 · Cited by 66
DNA-methylation gene network dysregulation in peripheral blood lymphocytes of schizophrenia patients
Auta, J., Smith, R. C., Dong, E., Tueting, P. A., Sershen, H. W., Boules, S., Lajtha, Á., Davis, J. M., & Guidotti, A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.030 · Cited by 66
Guidotti, G., Calabrese, F., Auletta, F., Olivier, J., Racagni, G., Homberg, J. R., & Riva, M. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.252 · Cited by 71
Xi, D., Keeler, B. E., Zhang, W., Houlé, J. D., & Gao, W. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.09.013 · Cited by 69
Koziol, L. F., Budding, D. E., & Chidekel, D. (2010) · The Cerebellum · doi:10.1007/s12311-010-0192-7 · Cited by 66
Prefrontal circuit organization for executive control
Kamigaki, T. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.08.017 · Cited by 69
Uliana, D. L., Lisboa, J. R., Gomes, F. V., & Grace, A. A. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116298 · Cited by 71
Lucas, E. K., Dougherty, S., McMeekin, L. J., Reid, C. S., Dobrunz, L. E., West, A. B., Hablitz, J. J., & Cowell, R. M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1222-14.2014 · Cited by 65
Increased density of GABAA receptors in the superior temporal gyrus in schizophrenia
Deng, C., & Huang, X. (2005) · Experimental Brain Research · doi:10.1007/s00221-005-0290-9 · Cited by 65
Bernstein, H., Krause, S., Krell, D., Dobrowolny, H., WOLTER, M., Stauch, R., RANFT, K., Dános, P., Jirikowski, G. F., & Bogerts, B. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.077 · Cited by 65
A computational neuroscience approach to schizophrenia and its onset
Rolls, E. T., & Deco, G. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.09.001 · Cited by 67
Starc, M., Murray, J. D., Santamauro, N. P., Savić, A., Diehl, C., Cho, Y., Srihari, V. H., MORGAN, P. T., Krystal, J. H., Wang, X., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.10.011 · Cited by 70
Zhou, Z., Zhang, G., Li, X., Liu, X., Wang, N., Qiu, L., Liu, W., Zuo, Z., & Yang, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8798-2 · Cited by 64
Nomura, T., Musial, T. F., Marshall, J. J., Zhu, Y., Remmers, C. L., Xu, J., Nicholson, D. A., & Contractor, A. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2893-16.2017 · Cited by 64
Glutamate as a mediating transmitter for auditory hallucinations in schizophrenia: A 1H MRS study
Hugdahl, K., Craven, A. R., Nygård, M., Løberg, E.-M., Berle, J. Ø., Johnsen, E., Kroken, R., Specht, K., Andreassen, O. A., & Ersland, L. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.11.015 · Cited by 64
Abe, Y., Namba, H., Kato, T., Iwakura, Y., & Nawa, H. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3477-10.2011 · Cited by 66
Hasan, A., Wobrock, T., Grefkes, C., Labusga, M., Levold, K., Schneider-Axmann, T., Falkai, P., Müller, H., Klosterkötter, J., & Bechdolf, A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.005 · Cited by 64
Eggan, S. M., Mizoguchi, Y., Stoyak, S. R., & Lewis, D. A. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhp179 · Cited by 64
Self-citationSapkota, K., Mao, Z., Synowicki, P., Lieber, D., Liu, M., Ikezu, T., Gautam, V., & Monaghan, D. T. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.230391 · Cited by 66
Hajós, M. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.05.005 · Cited by 64
Mahar, I., Albuquerque, M. S., Mondragon-Rodriguez, S., Cavanagh, C., Davoli, M. A., Chabot, J.-G., Williams, S., Mechawar, N., Quirion, R., & Krantic, S. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00327 · Cited by 63
Cross-ancestry atlas of gene, isoform, and splicing regulation in the developing human brain
Wen, C. H., Margolis, M. P., Dai, R., Zhang, P., Przytycki, P. F., Vo, D., Bhattacharya, A., Matoba, N., Tang, M., Jiao, C., et al. (2024) · Science · doi:10.1126/science.adh0829 · Cited by 65
Regulating Cortical Oscillations in an Inhibition-Stabilized Network
Jadi, M. P., & B, T. J. S. A. (2014) · Proceedings of the IEEE · doi:10.1109/jproc.2014.2313113 · Cited by 63
Abnormal Stress Responsivity in a Rodent Developmental Disruption Model of Schizophrenia
Zimmerman, E. C., Bellaire, M., Ewing, S. G., & Grace, A. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.110 · Cited by 66
Kalirin, a Key Player in Synapse Formation, Is Implicated in Human Diseases
Mandela, P., & Ma, X. (2012) · Neural Plasticity · doi:10.1155/2012/728161 · Cited by 65
Gene–environment interactions and construct validity in preclinical models of psychiatric disorders
Burrows, E. L., McOmish, C. E., & Hannan, A. J. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.011 · Cited by 63
Boley, A. M., Perez, S. M., & Lodge, D. J. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.05.005 · Cited by 66
Renard, J., Rushlow, W. J., & Laviolette, S. R. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00281 · Cited by 62
Altered organization of cortical interneurons in rats exposed to ethanol during neonatal life
Granato, A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.11.024 · Cited by 62
Altered Cortical GABA Neurotransmission in Schizophrenia: Insights into Novel Therapeutic Strategies
Stan, A. D., & Lewis, D. A. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112800784925 · Cited by 64
Self-citationDNA Methylation and Schizophrenia: Current Literature and Future Perspective
Magwai, T., Shangase, K. B., Oginga, F. O., Chiliza, B., Mpofana, T., & Xulu, K. R. (2021) · Cells · doi:10.3390/cells10112890 · Cited by 68
Byrns, C. N., Pitts, M. W., Gilman, C. A., Hashimoto, A. C., & Berry, M. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.540682 · Cited by 64
Morita, Y., Callicott, J. H., Testa, L. R., Mighdoll, M. I., Dickinson, D., Chen, Q., Tao, R., Lipska, B. K., Kolachana, B. S., Law, A. J., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1423-13.2014 · Cited by 64
Cognition-Emotion Dysinteraction in Schizophrenia
Anticevic, A., & Corlett, P. R. (2012) · Frontiers in Psychology · doi:10.3389/fpsyg.2012.00392 · Cited by 66
Costa, E., Chen, Y., Dong, E., Grayson, D. R., Kundaković, M., Maloku, E., Ruzicka, W. B., Satta, R., Veldić, M., Zhubi, A., et al. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.9.1.87 · Cited by 62
Schallmo, M., Sponheim, S. R., & Olman, C. A. (2015) · Psychological Medicine · doi:10.1017/s0033291715001439 · Cited by 63
Lesage, A., & Steckler, T. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.12.043 · Cited by 63
Bacolla, A., Collins, J., Gold, B., Chuzhanova, N. A., Yi, M., Stephens, R. M., Stefanov, S. A., Olsh, A., Jakupciak, J. P., Dean, M. C., et al. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl354 · Cited by 62
Pirbhoy, P. S., Rais, M., Lovelace, J. W., Woodard, W., Razak, K. A., Binder, D. K., & Ethell, I. M. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15037 · Cited by 62
Ike, K. G. O., de Boer, S. F., Buwalda, B., & Kas, M. J. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.06.030 · Cited by 64
Epigenetic signaling in schizophrenia
Ibi, D., & González‐Maeso, J. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.06.003 · Cited by 62
Mocci, G., Jiménez-Sánchez, L., Adell, A., Cortés, R., & Artigas, F. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.021 · Cited by 64
Nakatani-Pawlak, A., Yamaguchi, K., Tatsumi, Y., Mizoguchi, H., & Yoneda, Y. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1576 · Cited by 61
Mitchell, A., Jiang, Y., Peter, C. J., & Akbarian, S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.020 · Cited by 65
DNA Methylation in Schizophrenia
Pries, L.-K., Gülöksüz, S., & Kenis, G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_12 · Cited by 61
Lee, S. Y., Földy, C., Szabadics, J., & Soltész, I. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1970-11.2011 · Cited by 65
Lam, P., Newland, J., Faull, R. L. M., & Kwakowsky, A. (2023) · Molecules · doi:10.3390/molecules28031344 · Cited by 59
GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia
Vohs, J. L., Chambers, R. A., Krishnan, G. P., O’Donnell, B. F., Berg, S. A., & Morzorati, S. L. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990307 · Cited by 60
Casey, D. E., Daniel, D. G., Tamminga, C. A., Kane, J. M., Tran-Johnson, T. K., Wozniak, P., Abi‐Saab, W., Baker, J. M., Redden, L., Greco, N., et al. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.209 · Cited by 60
Yang, J., Zhang, J., Chen, X., Geng, H.-Y., Ye, M., Spitzer, N. C., Luo, J., Duan, S., & Li, X.-M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1584-13.2013 · Cited by 62
Pehrson, A. L., Bondi, C. O., Totah, N. K. B., & Moghaddam, B. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2792-z · Cited by 60
Combined transcranial magnetic stimulation and electroencephalography: Its past, present and future
Daskalakis, Z. J., Farzan, F., Radhu, N., & Fitzgerald, P. B. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.045 · Cited by 67
Cossart, R. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.10.003 · Cited by 64
Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?
Stone, J. M. (2011) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125311400779 · Cited by 60
Neural ECM in addiction, schizophrenia, and mood disorder
Lubbers, B. R., Smit, A. B., Spijker, S., & van den Oever, M. C. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63486-3.00012-8 · Cited by 62
Scheyltjens, I., & Arckens, L. (2016) · Neural Plasticity · doi:10.1155/2016/8723623 · Cited by 71
Donegan, J. J., Tyson, J. A., Branch, S. Y., Beckstead, M. J., Anderson, S. A., & Lodge, D. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.121 · Cited by 60
Iwata, Y., Nakajima, S., Plitman, E., Mihashi, Y., Caravaggio, F., Chung, J. K., Kim, J., Gerretsen, P., Mimura, M., Remington, G. J., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.03.016 · Cited by 60
Transcranial magnetic stimulation on the modulation of gamma oscillations in schizophrenia
Farzan, F., Barr, M. S., Sun, Y., Fitzgerald, P. B., & Daskalakis, Z. J. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06543.x · Cited by 59
Harrison, E. L., & Baune, B. T. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.31 · Cited by 60
Möller, M., Swanepoel, T., & Harvey, B. H. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn5003368 · Cited by 60
Meier, P., & Reinagel, P. (2011) · Journal of Vision · doi:10.1167/11.9.1 · Cited by 59
Zhang, Z., & Sun, Q. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20844 · Cited by 61
Impact of glutamate levels on neuronal response and cognitive abilities in schizophrenia
Falkenberg, L. E., Westerhausen, R., Craven, A. R., Johnsen, E., Kroken, R. A., L⊘berg, E.-M., Specht, K., & Hugdahl, K. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.03.014 · Cited by 59
Qiu, L.-L., Luo, D., Zhang, H., Shi, Y. S., Li, Y.-J., Wu, D., Chen, J., Ji, M., & Yang, J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00234 · Cited by 59
Blot, K., Kimura, S.-I., Bai, J., Kemp, A., Manahan-Vaughan, D., Giros, B., Tzavara, E., & Otani, S. (2015) · Cerebral Cortex · doi:10.1093/cercor/bht329 · Cited by 58
Attractor cortical neurodynamics, schizophrenia, and depression
Rolls, E. T. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01333-7 · Cited by 63
Markedly Lower Glutamic Acid Decarboxylase 67 Protein Levels in a Subset of Boutons in Schizophrenia
Rocco, B. R., Lewis, D. A., & Fish, K. N. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.022 · Cited by 61
Self-citationDecreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease
Lanoue, A. C., Dumitriu, A., Myers, R. H., & Soghomonian, J. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.09.001 · Cited by 58
Metadata
- Authors
- Lewis, D. A., Hashimoto, T., & Volk, D. W.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Lewis, David A.
- Venue
- Nature Reviews Neuroscience
- Published
- 2005-04
- Volume
- 6
- Issue
- 4
- Pages
- 312-324
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2089912569
- Cited by
- 2,297
- References
- 123
- Citations by year
- 2026: 36 · 2025: 51 · 2024: 63 · 2023: 48 · 2022: 70 · 2021: 86 · 2020: 77 · 2019: 94 · 2018: 102 · 2017: 89 · 2016: 123 · 2015: 148 · 2014: 132 · 2013: 167 · 2012: 151
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- schizophrenia, cortical inhibitory neurons, parvalbumin interneurons, GABA synthesis, dorsolateral prefrontal cortex, working memory, perisomatic inhibition, cognitive impairment
- MeSH terms
- Animals, Cerebral Cortex, Humans, Nerve Net, Neural Inhibition, Neurons, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
